Overview

Flexible Insulin Therapy Untethered Insulin Regimen in Avidly Exercising Patients With Type 1 Diabetes: FIT Untethered

Status:
Unknown status

Trial end date:
2019-06-30

Target enrollment:

Participant gender:

Summary

The overall objective of this study is to evaluate glycemic control and patient-reported outcomes in patients with Type 1 diabetes (T1D) who use insulin degludec and continuous subcutaneous insulin infusion in a combination untethered regimen during moderate or high-intensity exercise.

Phase:

Phase 4

Details

Lead Sponsor:

LMC Diabetes & Endocrinology Ltd.

Treatments:

Insulin
Insulin, Globin Zinc
Insulin, Long-Acting